Home › Biotechnology › Biomarkers
Biomarkers Market Research Reports & Consulting
Biomarkers play a vital role in diagnosis and drug discovery. The reports in this category cover the markets for biomarker applications, technologies, products, and services. The biomarker applications segment covers markets such as personalized medicine and the diagnosis and treatment markets for various disease conditions such as cancer, cardiovascular diseases, neurological disorders, and autoimmune diseases. The applications segment also includes the drug discovery market, which in turn covers submarkets such as drug targets, ADME-TOX profiling, and process quality assurance in drug development.
The biomarker technologies segment is classified into the pre-genomic and post-genomic technology markets. The former includes technologies such as enzyme and metabolite assays, immunodiagnostics, and molecular diagnostics; while the latter includes technologies such as transcriptomics, metabolites and imaging biomarkers. The biomarker services segment is bifurcated into the markets for pre- and post-clinical services such as sample preparation, mRNA analysis and miRNA analysis, antibody development, assay development and production, and validation and reporting.
Our research reports analyze and forecast the revenues for all of these markets; and also provide comprehensive data on the factors affecting market growth, such as regulatory issues on genomics, proteomics, and molecular diagnostics in various geographies. see less
Biomarkers play a vital role in diagnosis and drug discovery. The reports in this category cover the markets for biomarker applications, technologies, products, and services. The biomarker applications segment covers markets such as personalized medicine and the diagnosis and treatment markets f ....see more
Biochips Market by Type (DNA Chip (Genomics, Drug Discovery, Gene Expression) Lab-on-a-chip (IVD & POC, Proteomics), Protein Chips), End user (Academics Institutes, Diagnostics Centers), Fabrication Technology (Microarrays, Microfluidics) - Forecast to 2020
The biochips market is expected to reach USD 17.75 Billion by 2020 from USD 7.63 Billion in 2015, growing at a CAGR of 18.4% during the forecast period (2015–2020). Increasing adoption of personalized medicine, growing applications of biochips, and technological advancements are the major drivers for the biochips market. However, unclear regulatory guidelines, high instrumentation costs, and absolute quantification of specific mRNA may restrain the market growth to a certain extent.
|May 2016||$ 5650|
Cancer Biomarkers Market by Tumor (Breast, Lung, Prostate), Type (Protein & Genetic Biomarkers), Profiling Technology (Proteomics, Genomics, Imaging, Immunoassay), Application (Diagnostic, Drug Discovery, Prognostic) & Geography - Global Forecast to 2020
The global cancer biomarkers market has experienced substantial growth over the last couple of years. This market is expected to grow at a CAGR of 11.6% from 2015 to 2020. Factors such as rising incidence of cancer; technological advancements in omics technologies; favorable government funding for cancer research; increased demand for personalized medicines in cancer therapies; and increased use of biomarkers in drug discovery development and clinical trials are expected to fuel the growth of the cancer biomarkers market during the forecast period. The global cancer biomarkers market is expected to reach USD 15,973.8 Million by 2020, at a CAGR of 11.6% from 2015 to 2020.
|August 2015||$ 5650|
Biomarkers Market by Product (Consumables, Services), Type (Predictive, Pharmacodynamic, Safety), Application (Diagnostics, Drug Discovery, Personalized Medicine) & by Disease Indication (Cardiovascular, Immunological) - Global Forecast to 2020
The global biomarkers market is expected to reach $45.55 Billion by 2020 from $24.10 Billion in 2015, at a CAGR of 13.58% between 2015 and 2020. Increasing healthcare expenditure & R&D spending and the increasing utility of biomarkers for diagnostics are expected to drive the market. Market growth will also be aided by the low cost of clinical trials in developing countries and new initiatives undertaken for biomarker research. On the other hand, the need for high capital investment, low benefit-cost ratio, poorly suited regulatory & reimbursement systems, and the high cost of tests and sample collection & storage are the major factors restraining the growth of this market.
|July 2015||$ 5650|
Vital Signs Monitoring Market - Landscape Analysis of Blood Pressure Monitoring Devices, Pulse Oximeters and Temperature Monitoring Devices - Forecasts up to 2018
The word “vital” connotes the most significant requirement for sustaining healthy life. Blood pressure, respiratory rate, heart rate and body temperature within a normal range are necessary for the survival of human life and these parameters are referred to as vital signs.
|August 2013||$ 5650|